Search
Partnering in Retinal Health HP OCTOBER 2024 CORP_1.pdf
Our Stories
Our Stories
Partnering in RBB HP OCTOBER CORP.pdf
Partnering in Biotherapeutics HP OCTOBER 2024 CORP_1.pdf
Partnering in Technologies HP OCTOBER 2024 CORP.pdf
Avenciguat (BI 685509): sGC activator | SSc
Avenciguat (BI 685509): sGC activator | SSc
Nerandomilast (BI 1015550): PDE4B inhibitor
Nerandomilast (BI 1015550): PDE4B inhibitor
Nerandomilast (BI 1015550): PDE4B inhibitor
Nerandomilast (BI 1015550): PDE4B inhibitor
Iclepertin: GlyT1 inhibitor
Iclepertin: GlyT1 inhibitor
BI 764198: TRPC6 inhibitor
BI 764198: TRPC6 inhibitor
Heart disease modulator
TRPC6 inhibitor
PDE4B inhibitor
sGC activator
GlyT1 inhibitor
CatC inhibitor
Oxidase Inhibitor
Respiratory
Human Pharma Clinical Pipeline Respiratory therapeutic area
Aldosterone synthase inhibitor
Ion channel inhibitor
Ion channel inhibitor
KRAS multi-inhibitor
KRAS multi-inhibitor
Oxidase Inhibitor
Oxidase Inhibitor
Immunomodulator
Immunomodulator